Newsfeeds Archive - Spark Newswire

1 minute read

News

Galapagos And Adaptimmune Enter Clinical Collaboration To License Next-Generation TCR T-Cell Therapy For Cancer Using Decentralized Manufacturing Platform

May 30, 4:02 PM

Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next generation MAGE-A4 TCR T-cell therapy) produced on Galapagos' decentralized manufacturing platform

ADAP

2 minute read

Galapagos And Blood Centers Of America Collaborate To Expand Galapagos’ Decentralized CAR-T Manufacturing Network In The U.S.

By Benzinga Newsdesk

May 15, 4:03 PM

BCA's national network of blood centers will provide decentralized manufacturing services for Galapagos' CAR-T product candidates, close to cancer treatment centersCollaboration enables rapid deployment of Galapagos'

GLPG

2 minute read

Galapagos Q1 EPS €1.40 Vs €0.40 YoY; Revenue €62.4 Million Vs €58.6 Million YoY

By Benzinga Newsdesk

May 2, 4:37 PM

Results from our continuing operationsTotal operating loss from continuing operations for the three months ended 31 March 2024 was €33.1 million, compared to an operating loss of €14.2 million for the three months ended

GLPG

2 minute read

Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: Analyst

By Vandana Singh

April 1, 2:37 PM

BofA Securities downgrades Galapagos to underperform due to limited near-term catalysts and competitive challenges in crowded markets.

GILD

1 minute read

European Drugmaker Galapagos Collaborates With Biotech BridGene Biosciences To Develop Cancer Treatments

By Vandana Singh

January 3, 5:01 PM

On Wednesday, BridGene Biosciences Inc. announced a strategic collaboration and licensing agreement with Galapagos NV (NASDAQ: GLPG).

GLPG

1 minute read

M&A
News

Galapagos Transforms Into Biotech Innovator, Sells Jyseleca Business To Alfasigma With Key Executive Transition

By Benzinga Newsdesk

January 2, 2:22 AM

In connection with the transaction, Galapagos expects to realize substantial savings ranging between €150 million and €200 million and will prioritize investments in its existing technology platforms of small

GLPG

29 minute read

Earnings

Earnings Scheduled For November 2, 2023

By Benzinga Insights

November 2, 4:56 AM

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.

AAPL

6 minute read

Galapagos Concludes Strategic Evaluation And Signs Letter Of Intent To Transfer Jyseleca Business To Alfasigma; Co Will Receive A €50M Upfront, Potential Milestone Payments Totaling €120M And Mid-single To Mid-double-digit Royalties On European Sales

By Benzinga Newsdesk

October 30, 4:38 PM

Transaction would enable Galapagos to realize considerable annualized savings and accelerate its pipeline focused on developing transformational medicinesAims to preserve the Jyseleca® (filgotinib) business and a

GLPG